Mark A. Underwood, M.D.

UC Davis, Chief of the Division of Neonatology

http://www.ucdmc.ucdavis.edu/publish/providerbio/pediatrics/1022/

Research Interests

Clinical trials of probiotics and prebiotics, the role of Paneth cells in NEC prevention and pathogenesis, human milk and its impact on the gut microbiota and NEC prevention

Current Projects

Cohort study of very low birth weight infants, clinical trial of a probiotic in term infants

Recent Publications

Underwood MA, German JB, Lebrilla CB, Mills DA 2015 Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatric Res 77(1-2):229-35.

Dallas DC, Smink CJ, Robinson RC, Tian T, Guerrero A, Parker EA, Smilowitz JT, Hettinga KA, Underwood MA, Lebrilla CB, German JB, Barile D 2015 Endogenous human milk peptide release is greater following preterm birth than term birth. J Nutr 145(3):425-33.

Underwood MA, Gaerlan SC, De Leoz MLA, Dimapasoc L, Kalanetra KM, Lemay DG, German JB, Mills DA, Lebrilla CB 2015 Human Milk Oligosaccharides in Premature Infants: Absorption, Excretion and Influence on the Intestinal Microbiota. Pediatr Res. 78(6):670-7.

Lewis ZT, Shani G, Masarweh C, Popovich M, Frese SA, Sela DA, Underwood MA, Mills DA. 2015 Identifying species and subspecies of bifidobacteria in the context of probiotic products. Pediatr Res. 79(3):445-52.

Powell WT, Borghese RA, Kalanetra KM, Mirmiran M, Mills DA, Underwood MA. Probiotic administration in infants with gastroschisis: a pilot randomized placebo-controlled trial. J Pediatr Gastroenterol Nutr. 62(6):852-7.

Vongbhavit K, Underwood MA. 2016 Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant. Clinical Therapeutics. 38(4):716-32.

 

 

 

 

%d bloggers like this: